SFM
ZSAN

Sphera Funds Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Sphera Funds Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-89
Closed -$452K – 148
2015
Q2 		$452K Sell
89
-175
-66% -$1.08M 0.04% 125
2015
Q1 		$1.87M Buy
+264
New +$1.98M 0.19% 112

Other funds holding ZSAN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Sphera Funds Management's ZSAN Position: Q3 2015 in Review

Sphera Funds Management sold out of Zosano Pharma Corporation (ZSAN) in Q3 2015, closing a stake of 89 shares — an estimated $452K sold.

Sphera Funds Management first reported a position in ZSAN in Q1 2015 and held it in 2 quarters. The position peaked at $1.87M in Q1 2015. 15 funds tracked by Wall St. Rank hold ZSAN as of Q3 2015.

  • Sphera Funds Management reported no remaining Zosano Pharma Corporation position as of Q3 2015 after selling out during the quarter.
  • Sphera Funds Management sold 89 Zosano Pharma Corporation shares in Q3 2015, an estimated $452K.
  • Sphera Funds Management first reported a position in Zosano Pharma Corporation in Q1 2015 and held it in 2 quarters.
  • Sphera Funds Management's Zosano Pharma Corporation position peaked at $1.87M in Q1 2015.
  • 15 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2015.

Based on Sphera Funds Management's 13F filing for Q3 2015, filed 16 Nov 2015.